Valued at $21.4 billion, Natera (NTRA) is a clinical genetic testing company focused on non-invasive cell-free DNA (cfDNA) ...

Cornell researchers developed machine-learning models that can sift through cell-free RNA and identify key biomarkers for ...

Fetal Focus uses non-invasive prenatal testing to detect key genetic conditions without needing the father’s DNA, keeping ...

In European countries, cell-free DNA has already been used as a standard of care to determine fetal antigen status and guide pregnancy management. Data was derived from Rego S, et al. Obstet ...

More information: Mohamed Adil et al, Preeclampsia risk prediction from prenatal cell-free DNA screening, Nature Medicine (2025). DOI: 10.1038/s41591-025-03509-w ...

When a tumor starts to grow in the body, small bits of its genetic material may break away and float off into the bloodstream. This so-called cell free DNA can be used to identify cancer at very early ...

Cell-free DNA testing uses a small amount of a person's blood and tests it for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory ...

AI 'liquid biopsies' using cell-free DNA, protein biomarkers, could aid early detection of ovarian cancer Date: October 2, 2024 Source: Johns Hopkins Medicine Summary: A blood test that uses ...

For the new cell-free DNA testing, a small amount of a person's blood is tested for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory ...

Of the millions of pregnant women each year who have a cell-free DNA test, 1 in 10,000 will get a result back that is unusual and difficult to interpret, neither positive or negative for a fetal ...